v3.26.1
Cover - $ / shares
 3 Months Ended
Mar. 31, 2026
Jun. 29, 2026
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description This Amendment No. 1 on Form 10-Q/A amends the Quarterly Report on Form 10-Q of ProPhase Labs, Inc. (the “Company”) for the quarterly period ended March 31, 2026, originally filed with the Securities and Exchange Commission on June 30, 2026.  *This Amendment is being filed solely because the Company’s independent registered public accounting firm had not finalized its review of the Company’s interim financial statements prior to the filing of the Original Report, as required by Rule 10-01(d) of Regulation S-X. The review is substantially complete, and the Company currently expects the auditors to finalized within one to two days.  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2026  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --12-31  
Entity File Number 000-21617  
Entity Registrant Name ProPhase Labs, Inc.  
Entity Central Index Key 0000868278  
Entity Tax Identification Number 23-2577138  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 626 RXR Plaza  
Entity Address, Address Line Two 6th Floor  
Entity Address, City or Town Uniondale  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 11556  
City Area Code (516)  
Local Phone Number 989-0763  
Title of 12(b) Security Common Stock, par value $0.0005  
Trading Symbol PRPH  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,016,204
Entity Listing, Par Value Per Share $ 0.0005